Genmab reported DKK24.48B in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1124.07M 83.38M
Amarin AMRN:US $ 580.04M 61.07M
Amgen AMGN:US $ 2419M 1503M
Artemis Alpha ATS:LN 12.41B 3.51B
AstraZeneca AZN:LN 2951310.75M 184237.79M
Bayer BAYN:GR € 38019M 582M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Bluebird Bio BLUE:US $ 180.12M 83.14M
Exelixis EXEL:US $ 2391.26M 97.41M
Fresenius Medical Care FME:GR € 15451M 2216.5M
Galapagos GLPG:NA € 2646.9M 0.31M
Genmab GEN:DC DK 24482M 1763M
GlaxoSmithKline GSK:LN 1637400M 19300M
GN Store Nord GN:DC DK 6638M 622M
Hikma Pharmaceutical HIK:LN 178.73B 2.59B
Immunogen IMGN:US $ 249.83M 56.64M
Insmed INSM:US $ 44.24M 75.64M
Lonza Group LONN:SW 10.01B 261M
Merck MRK:GR € 25955M 3036M
Novartis NOVN:VX SF 62925M 1385M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
William Demant Holding WDH:DC 8.18B 202M